Jan. 26, 2015 — Scientists have revealed how a type of cancer-causing virus outwits the human body's immune response. The discovery might help explain why some cancer therapies that incorporate interferon fail to ... full story

Jan. 12, 2015 — Targeting a cell 'survival' protein could help treat some lymphomas, including those cancers with genetic defects that make them resistant to many existing therapies, researchers have discovered. ... full story

Dec. 18, 2014 — Programmed cell death is a mechanism that causes defective and potentially harmful cells to destroy themselves. It serves a number of purposes in the body, including the prevention of malignant tumor ... full story

Dec. 7, 2014 — Eighty-seven percent of Hodgkin lymphoma patients who participated in an early-phase immunotherapy clinical trial experienced cancer remission, scientists report. The results provide some of the most ... full story

Dec. 7, 2014 — In a late-stage clinical trial, Hodgkin lymphoma patients who received brentuximab vedotin post-transplant lived longer without disease progression than patients who received only supportive care, ... full story

Dec. 7, 2014 — In recent years, a number of scientific breakthroughs have led to the development of drugs that unleash the power of the immune system to recognize and attack cancer. For Classical Hodgkin lymphoma ... full story

Nov. 17, 2014 — The Malt1 protein is one of the most important control centers in human immune cells and a real all-rounder. Genetic defects in it can lead to the development of lymphatic cancer (lymphoma). A ... full story

Oct. 22, 2014 — The same specialized immune cells that patrol the body and spot infections also trigger the expansion of immune organs called lymph nodes, scientists have discovered. The immune system defends the ... full story

Featured Videos

Art and Science Come Together in Nikon Time-Lapse Competition

Reuters (Jan. 15, 2013) — A time-lapse movie showing the immune response in the lymph nodes of a mouse edged out a fruit fly sperm fight for top honors at this year&apos;s Nikon "Small World in Motion Photomicrography" competition. In it&apos;s second year, the competition showcases 2012&apos;s best time-lapse imagery as seen through through a microscope.

Orangutan's Cancer Treatment Similar to Humans

AP (Sep. 17, 2012) — Peanut is the first documented case of an orangutan undergoing a cancer treatment that is similar to that of a human. She began treatment for non-Hodgkin lymphoma in early August and is expected to receive six treatments of chemotherapy.

MultiVu (Aug. 21, 2012) — Sutter Neuroscience Institute, a recognized Center of Excellence, and CBR (Cord Blood Registry), the world&apos;s largest stem cell bank, are launching the first FDA- approved clinical trial to assess the use of a child&apos;s own cord blood stem cells to treat select patients with autism. This first-of-its-kind placebo controlled study will evaluate the ability of an infusion of cord blood stem cells to help improve language and behavior. The study is in conjunction with the Sutter Institute for Medical Research.

Jan. 12, 2015 — Targeting a cell 'survival' protein could help treat some lymphomas, including those cancers with genetic defects that make them resistant to many existing therapies, researchers have ... full story

Dec. 18, 2014 — Programmed cell death is a mechanism that causes defective and potentially harmful cells to destroy themselves. It serves a number of purposes in the body, including the prevention of malignant tumor ... full story

Dec. 11, 2014 — Apheresis, the simple process of drawing blood, becomes a powerful therapeutic in extracorporeal photopherisis (ECP) according to clinicians and scientists. In the case of ECP, investigators' ... full story

Dec. 8, 2014 — New treatment combinations and targeted therapies for lymphoma and multiple myeloma are improving outcomes for vulnerable patient populations with hard-to-treat disease, according to new ... full story

Dec. 7, 2014 — Eighty-seven percent of Hodgkin lymphoma patients who participated in an early-phase immunotherapy clinical trial experienced cancer remission, scientists report. The results provide some of the most ... full story

Dec. 7, 2014 — In a late-stage clinical trial, Hodgkin lymphoma patients who received brentuximab vedotin post-transplant lived longer without disease progression than patients who received only supportive care, ... full story

Dec. 7, 2014 — In recent years, a number of scientific breakthroughs have led to the development of drugs that unleash the power of the immune system to recognize and attack cancer. For Classical Hodgkin lymphoma ... full story

Nov. 19, 2014 — Patients with B-cell Non-Hodgkin lymphomas and advanced solid tumours have responded to a new drug that is being tested for the first time in humans in a phase I clinical ... full story

Nov. 17, 2014 — The Malt1 protein is one of the most important control centers in human immune cells and a real all-rounder. Genetic defects in it can lead to the development of lymphatic cancer (lymphoma). A ... full story

Nov. 5, 2014 — The search for genetic and environmental links to lymphomas, resulting in the largest epidemiology and genome-wide association studies of non-Hodgkin lymphoma ever conducted, is coming to a close. ... full story

Oct. 22, 2014 — The same specialized immune cells that patrol the body and spot infections also trigger the expansion of immune organs called lymph nodes, scientists have discovered. The immune system defends the ... full story

Oct. 22, 2014 — The 59-year-old woman had complained of chest pain and shortness of breath. A biopsy revealed that she had an unusual type of 'heart cancer' called cardiac lymphoma. But a week after ... full story

Oct. 19, 2014 — At least 2 percent of people over age 40 and 5 percent of people over 70 have mutations linked to leukemia and lymphoma in their blood cells, according to new research. Mutations in the body's ... full story

Oct. 6, 2014 — Cases of possible association between breast implants and a form of lymphoma that may develop tumors at a later stage is currently under investigation. The researchers conclude that breast implants ... full story

Sep. 17, 2014 — Positron emission tomography/computed tomography (PET-CT) is more accurate than conventional CT scanning in measuring response to treatment and predicting survival in patients with follicular ... full story

ScienceDaily features breaking news and videos about the latest discoveries in health, technology, the environment, and more -- from major news services and leading universities, scientific journals, and research organizations.